Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Pharmacology Research & Perspectives|October 23, 2024
The hydroxycarboxylic acid receptor HCA2 is required for the protective effect of ketogenic diet in epilepsyJill C Richardson, Guy A Higgins, Neil Upton, et al.
The Journal of Biological Chemistry|January 14, 2014
Pharmacological and genetic targeting of the PI4KA enzyme reveals its important role in maintaining plasma membrane phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate levelsNaveen Bojjireddy, Janos Botyanszki, Gerald Hammond, et al.
The Biochemical Journal|July 31, 2016
Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitorsGenta Ito, Kristina Katsemonova, Francesca Tonelli, et al.
Neuroscience Letters|July 3, 2020
Ethologically based behavioural and neurochemical characterisation of mice with isoform-specific loss of dysbindin-1A in the context of schizophreniaColm M P O'Tuathaigh, Lieve Desbonnet, Christina Payne, et al.
American Journal of Human Genetics|March 15, 2006
Mutation in Rab3 GTPase-activating protein (RAB3GAP) noncatalytic subunit in a kindred with Martsolf syndromeIrene A Aligianis, Neil V Morgan, Marina Mione, et al.
Plos One|September 25, 2014
Characterisation of a K390R ITK kinase dead transgenic mouse--implications for ITK as a therapeutic targetAngela Deakin, Graham Duddy, Steve Wilson, et al.
Immunogenetics|May 17, 2005
The design and implementation of the immune epitope database and analysis resourceBjoern Peters, John Sidney, Phil Bourne, et al.
The Journal of Molecular Diagnostics : JMD|July 11, 2006
A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infectionsP Lewis White, Richard Barton, Malcolm Guiver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancerGraham S Taylor, Hui Jia, Kevin Harrington, et al.
The Journal of Investigative Dermatology|March 21, 2021
A Potent and Selective Kallikrein-5 Inhibitor Delivers High Pharmacological Activity in Skin from Patients with Netherton SyndromeJohn Liddle, Veronique Beneton, Matthew Benson, et al.
Pageof 5